ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO519

Distal Convoluted Tubule-Specific Disruption of the COP9 Signalosome and CUL3 Activates the WNK4-SPAK-NCC Pathway

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1101 Fluid, Electrolyte, and Acid-Base Disorders: Basic

Authors

  • Cornelius, Ryan J., Oregon Health & Science University, Portland, Oregon, United States
  • Maeoka, Yujiro, Oregon Health & Science University, Portland, Oregon, United States
  • Bradford, Tanner, Oregon Health & Science University, Portland, Oregon, United States
  • Su, Xiao-Tong, Oregon Health & Science University, Portland, Oregon, United States
  • Yang, Chao-Ling, Oregon Health & Science University, Portland, Oregon, United States
  • Ellison, David H., Oregon Health & Science University, Portland, Oregon, United States
  • McCormick, James A., Oregon Health & Science University, Portland, Oregon, United States
Background

The disease Familial Hyperkalemic Hypertension (FHHt; also known as Gordon Syndrome) is caused by aberrant accumulation of WNK4 activating the NaCl cotransporter (NCC) in the distal convoluted tubule (DCT) of the kidney. Mutations in cullin 3 (CUL3) cause FHHt by disrupting interaction with its regulator, the COP9 signalosome (CSN). Deletion of Cul3 and Jab1 (the catalytically active CSN subunit) along the entire nephron causes an FHHt phenotype with activation of the WNK4-SPAK-NCC pathway. However, only a partial FHHt phenotype develops due to kidney injury. We hypothesized that DCT-specific deletion would more accurately model the disease.

Methods

We utilized NCC-Cre-ERT2 mice to delete Cul3 (DCT-Cul3-/-) and Jab1 (DCT-Jab1-/-) only in the DCT. Blood was collected for plasma electrolyte analysis, and kidneys were collected for Western blotting and immunofluorescent staining.

Results

Both DCT-Cul3-/- and DCT-Jab1-/- mice showed an FHHt-like phenotype, with increased WNK4, SPAK, and pNCC abundance. CUL3 inactivation in the DCT-Cul3-/- mice caused an increase in both KLHL3 (the CUL3 substrate adaptor for WNK4) and WNK4 abundance. WNK4 accumulated in DCT-Jab1-/- mice due to hyperactivation of CUL3, which caused decreased CUL3 and KLHL3 abundance. Both genotypes showed formation of pSPAK and WNK4 puncta, however, the number of WNK4 puncta was higher in DCT-Cul3-/- mice. Contrasting the disease, both genotypes showed no change in plasma K+, Cl-, or HCO3- at baseline, but the DCT-Jab1-/- mice became hyperkalemic when challenged with a high K+ diet. Additionally, over time DCT-Jab1-/- mice showed a large decrease in NCC abundance, which was not observed in the DCT-Cul3-/- mice. Interestingly, although Jab1 was deleted only in the DCT, the mice had increased abundance of KIM-1, a marker of proximal tubule injury.

Conclusion

DCT-specific knockout of both CUL3 and the cullin-RING-ligase regulator JAB1 led to an FHHt-like phenotype. Chronically, only DCT-Jab1-/- mice developed a large reduction in NCC abundance, suggesting the decrease is due to a direct JAB1 effect, or effects of JAB1 on other cullins.

Funding

  • NIDDK Support